Few insured individuals receive timely direct-acting antiviral treatment for hepatitis C
Few insured individuals with hepatitis C virus (HCV) infection receive timely direct-acting antiviral (DAA) treatment, according to research published in the Aug. 9 early-release issue of the U.S. Centers for Disease Control ...
Aug 11, 2022
0
2